XOMA SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fr...
July 23 2015 - 12:20PM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Xoma Corporation (NASDAQ: XOMA) concerning possible violations
of federal securities laws. The investigation concerns whether Xoma
Corporation and certain of its officers and/or directors have
violated Sections 10(b) and 20(a) of the Securities Exchange Act of
1934. On July 22, 2015, XOMA announced that a Phase III trial of
its treatment gevokizumab for Behcet’s disease in the eye missed
the primary endpoint of time to first acute ocular exacerbation. To
obtain additional information, go to:
http://zlk.9nl.com/xoma
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150723006143/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Apr 2023 to Apr 2024